Neuroendocrine Colon Cancer Is A Very Aggressive Disease
One of the more aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it's most fr...
One of the more aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it’s most frequently detected in its late stages when it is extremely hard to make treatments.
As the side effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumours are always malignant, and mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer end in death.
Though the possibilities of neuroendocrine carcinoma in colon are rare at best if one is affected the patient’s condition becomes much worse than patients who suffer from adenocarcinoma.
Research reveals that the results of this form of cancer do not differ with age, sex or tumour location. Though neuroendocrine colon carcinoma depends on which stage the tumour is in the usual trends reveal that most people show that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. But alternately in the majority of cases if said tumour is in stage 3 or 4, it is a laborious and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has few techniques to deal with this particular cancer. A more common technique that the doctors often use is immunohistochemical staining methods. This method assists the doctors to detect the severity of the neuroendocrine colon cancer and really helps determine the most helpful medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of said tumour with an antibody called A-80 which helps in identifying the quantum of neuroendocrine differentiation and nature of the damage on the patient’s health.
Neuroendocrine colon carcinoma is difficult to treat and a case study in which several patients suffered from colon carcinoma was examined, it was noted that the average survival rate related to this disease was approximately seven months. In the later stages these rates drop to less than five months. The great majority of these cases were initially detected as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery may not be a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to make note of carcinoma as soon as possible and provide proper medication for it.
The writer has more than one interesting site- checkout his Colon Carcinoma site and also his colon carcinoma.